Cyclacel Pharmaceuticals (CYCC) Stock Chart & Stock Price History $0.24 -0.01 (-5.31%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$0.24 0.00 (-0.20%) As of 05/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cyclacel Pharmaceuticals Stock Price Performance 5 Day Performance-12.21%1 Month Performance-9.11%3 Month Performance-26.58%6 Month Performance-61.00%Year-To-Date Performance-34.97%1 Year Performance-90.77% Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CYCC Stock Chart for Friday, May, 2, 2025 CYCC Chart by TradingView Cyclacel Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$0.26$0.24-5.31%$0.30$0.242.09 million shs$50.69 million04/30/2025$0.30$0.26-15.01%$0.28$0.244.71 million shs$53.53 million04/29/2025$0.29$0.30+6.48%$0.41$0.23109.14 million shs$62.99 million04/28/2025$0.28$0.29+2.44%$0.42$0.2510.96 million shs$59.15 million04/25/2025$0.23$0.28+21.62%$0.30$0.233.72 million shs$57.74 million04/24/2025$0.23$0.23-0.52%$0.24$0.22372,917 shs$47.48 million04/23/2025$0.23$0.23+2.04%$0.23$0.22559,375 shs$47.73 million04/22/2025$0.21$0.23+6.87%$0.23$0.2162,081 shs$46.78 million04/21/2025$0.23$0.21-6.63%$0.23$0.21117,456 shs$43.77 million04/18/2025$0.23$0.23$0.23$0.2156,980 shs$46.88 million Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$0.22$0.23+4.48%$0.23$0.2156,980 shs$46.88 million04/16/2025$0.23$0.22-5.67%$0.24$0.2190,763 shs$44.87 million04/15/2025$0.22$0.23+3.01%$0.25$0.2258,282 shs$1.44 million04/14/2025$0.24$0.22-6.82%$0.25$0.2297,377 shs$1.40 million04/11/2025$0.22$0.24+7.66%$0.24$0.22169,945 shs$1.50 million04/10/2025$0.23$0.22-2.20%$0.23$0.2126,709 shs$1.40 million04/09/2025$0.21$0.23+6.27%$0.23$0.20165,671 shs$1.43 million04/09/2025$0.21$0.23+6.27%$0.23$0.20165,671 shs$1.43 million04/08/2025$0.19$0.21+13.62%$0.22$0.20159,914 shs$1.34 million04/08/2025$0.19$0.21+13.62%$0.22$0.20159,914 shs$1.34 million04/07/2025$0.21$0.19-12.15%$0.21$0.17455,670 shs$1.18 million04/04/2025$0.23$0.21-6.96%$0.23$0.20206,468 shs$1.35 million04/03/2025$0.25$0.23-6.20%$0.25$0.23139,779 shs$1.45 million04/02/2025$0.27$0.25-8.85%$0.27$0.22303,064 shs$1.54 million04/01/2025$0.28$0.27-3.65%$0.28$0.26333,750 shs$1.69 million03/31/2025$0.30$0.28-6.62%$0.30$0.27187,430 shs$1.76 million Related Companies Candel Therapeutics Stock Chart Design Therapeutics Stock Chart Cidara Therapeutics Stock Chart enGene Stock Chart Rezolute Stock Chart Bright Minds Biosciences Stock Chart Humacyte Stock Chart Protalix BioTherapeutics Stock Chart Kodiak Sciences Stock Chart Acelyrin Stock Chart Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCC) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CYCC Stock Free CYCC Stock Alerts